icon-folder.gif   Conference Reports for NATAP  
 
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
 
 
 
A Next Generation HCV DAA Combination: Potent, Pangenotypic Inhibitors ABT-493 and ABT-530 With High Barriers to Resistance
 
 
  Reported by Jules Levin
AASLD Nov 7-11 Boston 2014
 
Teresa Ng, Tami Pilot-Mati as, Liangjun Lu, Thomas Reisch, Tanya Dekhtyar, Preethi Krishnan, Jill Beyer, Rakesh Tripathi, Ron Pithawalla, Armen Asatryan, Andrew Campbell, Jens Kort, Christine Collins
AbbVie Inc., North Chicago, Illinois, United States

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif